Multiple studies on AD patients show promising therapeutic effects on AD progression, including improved learning and memory, decreased oxidative stress, modified insulin resistance, improved behavioural performance on visual-spatial and executive/language tasks, decreased inflammation, mitochondrial dysfunction, gut barrier permeability, and DNA damage [234,235]. This evidence concerns the gene INS and Alzheimer disease.